Rapid Improvement in Disease Activity With Ixekizumab vs IL-23 and IL-12/23 Inhibitors in PsAOctober 21, 2024Psoriatic Arthritis
Rheumatology NewsRisk Assessment Tool Can Help Predict Fractures in CancerOctober 21, 2024Mixed TopicsOsteoporosis
Rheumatology NewsHow Doctors Use Music to Learn Faster and Perform BetterOctober 17, 2024Business of Medicine
Rheumatology NewsFewer Recurrent Cardiovascular Events Seen With TNF Inhibitor Use in Axial SpondyloarthritisOctober 15, 2024SpondyloarthropathiesAnkylosing spondylitis
Rheumatology News70% of Doctors Would Discharge Noncompliant Patients, Medscape Survey FindsOctober 15, 2024Business of Medicine
Rheumatology NewsGenetic Risk for Gout Raises Risk for Cardiovascular Disease Independent of Urate LevelOctober 15, 2024Gout
Rheumatology NewsGroup Aims to Better Define ‘Extraordinarily Heterogeneous’ Mast Cell Activation SyndromeOctober 15, 2024Lupus & Connective Tissue DiseasesLong COVID
